With a number of transcatheter therapies for mitral regurgitation expected to be available for clinical use in selected patients in the coming years, a new societal overview released by the ACC, the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, and the Society of Cardiovascular Angiography and Interventions Foundation contains several recommendations to “ensure that such innovative treatments are introduced into medical practice in the U.S. with appropriate safeguards.” Among the recommendations, the report highlights the need for professional societies, industry, payers and regulatory agencies to work collaboratively to promote needed research and ensure appropriate integration.

Keywords: Mitral Valve Insufficiency, Thoracic Surgery, United States, Cardiology Magazine, ACC Publications

< Back to Listings